“…In an attempt to better characterize the earliest white matter changes and their regional progression in the course of AD pathogenesis, recent DTI studies have more and more focused on asymptomatic at-risk populations, such as healthy subjects carrying AD-susceptibility genes, most notably the APOE4 allele (Bendlin et al, 2010; Kljajevic et al, 2014; Westlye, Reinvang, Rootwelt, & Espeseth, 2012; Xiong et al, 2011), but also other risk-associated candidate genes (Braskie et al, 2012, 2011; Forde et al, 2014; Liang, Li, et al, 2015; Lyall et al, 2014; Voineskos et al, 2011), or completely dominant familial AD mutations (Ringman et al, 2007; Ryan et al, 2013). Other recent studies examined white matter changes in asymptomatic individuals showing biomarker evidence of amyloid or tau pathology (Bendlin et al, 2012; Chao et al, 2013; Gold et al, 2014; Kantarci et al, 2014; Molinuevo et al, 2014; Racine et al, 2014; Stenset et al, 2011).…”